Barclays’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-402,691
| Closed | -$1.23M | – | 4648 |
|
|
2024
Q4 | $1.23M | Buy |
402,691
+229,336
| +132% | +$698K | ﹤0.01% | 2509 |
|
|
2024
Q3 | $900K | Buy |
173,355
+136,015
| +364% | +$706K | ﹤0.01% | 2680 |
|
|
2024
Q2 | $95K | Sell |
37,340
-2,982,002
| -99% | -$7.59M | ﹤0.01% | 3403 |
|
|
2024
Q1 | $14.9M | Buy |
3,019,342
+2,661,786
| +744% | +$13.1M | 0.01% | 847 |
|
|
2023
Q4 | $3.14M | Sell |
357,556
-176,766
| -33% | -$1.55M | ﹤0.01% | 1834 |
|
|
2023
Q3 | $6.13M | Buy |
534,322
+253,564
| +90% | +$2.91M | ﹤0.01% | 1043 |
|
|
2023
Q2 | $7.11M | Buy |
280,758
+2,823
| +1% | +$71.5K | ﹤0.01% | 1046 |
|
|
2023
Q1 | $8.95M | Sell |
277,935
-30,629
| -10% | -$987K | ﹤0.01% | 842 |
|
|
2022
Q4 | $5.7M | Buy |
308,564
+214,634
| +229% | +$3.96M | ﹤0.01% | 1044 |
|
|
2022
Q3 | $2.54M | Buy |
93,930
+48,724
| +108% | +$1.32M | ﹤0.01% | 1498 |
|
|
2022
Q2 | $625K | Buy |
45,206
+24,790
| +121% | +$343K | ﹤0.01% | 2411 |
|
|
2022
Q1 | $398K | Sell |
20,416
-88,519
| -81% | -$1.73M | ﹤0.01% | 2937 |
|
|
2021
Q4 | $1.78M | Buy |
108,935
+66,851
| +159% | +$1.09M | ﹤0.01% | 1873 |
|
|
2021
Q3 | $1.17M | Buy |
42,084
+14,786
| +54% | +$412K | ﹤0.01% | 2166 |
|
|
2021
Q2 | $809K | Sell |
27,298
-33,101
| -55% | -$981K | ﹤0.01% | 2234 |
|
|
2021
Q1 | $1.69M | Buy |
60,399
+31,982
| +113% | +$894K | ﹤0.01% | 2003 |
|
|
2020
Q4 | $805K | Sell |
28,417
-5,745
| -17% | -$163K | ﹤0.01% | 2091 |
|
|
2020
Q3 | $859K | Sell |
34,162
-2,108
| -6% | -$53K | ﹤0.01% | 2014 |
|
|
2020
Q2 | $886K | Buy |
36,270
+14,060
| +63% | +$343K | ﹤0.01% | 1998 |
|
|
2020
Q1 | $329K | Sell |
22,210
-33,017
| -60% | -$489K | ﹤0.01% | 2326 |
|
|
2019
Q4 | $896K | Buy |
55,227
+18,944
| +52% | +$307K | ﹤0.01% | 2365 |
|
|
2019
Q3 | $471K | Sell |
36,283
-5,220
| -13% | -$67.8K | ﹤0.01% | 2643 |
|
|
2019
Q2 | $538K | Buy |
41,503
+8,026
| +24% | +$104K | ﹤0.01% | 2679 |
|
|
2019
Q1 | $529K | Buy |
33,477
+17,260
| +106% | +$273K | ﹤0.01% | 2579 |
|
|
2018
Q4 | $326K | Sell |
16,217
-11,181
| -41% | -$225K | ﹤0.01% | 2497 |
|
|
2018
Q3 | $682K | Buy |
27,398
+14,988
| +121% | +$373K | ﹤0.01% | 2484 |
|
|
2018
Q2 | $341K | Sell |
12,410
-13,540
| -52% | -$372K | ﹤0.01% | 2482 |
|
|
2018
Q1 | $800K | Buy |
25,950
+6,814
| +36% | +$210K | ﹤0.01% | 1979 |
|
|
2017
Q4 | $684K | Buy |
19,136
+7,417
| +63% | +$265K | ﹤0.01% | 1873 |
|
|
2017
Q3 | $322K | Buy |
11,719
+547
| +5% | +$15K | ﹤0.01% | 2149 |
|
|
2017
Q2 | $294K | Sell |
11,172
-8,840
| -44% | -$233K | ﹤0.01% | 2219 |
|
|
2017
Q1 | $416K | Buy |
20,012
+11,930
| +148% | +$248K | ﹤0.01% | 2060 |
|
|
2016
Q4 | $168K | Buy |
8,082
+7,683
| +1,926% | +$160K | ﹤0.01% | 2381 |
|
|
2016
Q3 | $6K | Sell |
399
-3,041
| -88% | -$45.7K | ﹤0.01% | 3380 |
|
|
2016
Q2 | $47K | Buy |
3,440
+3,265
| +1,866% | +$44.6K | ﹤0.01% | 2595 |
|
|
2016
Q1 | $3K | Sell |
175
-278
| -61% | -$4.77K | ﹤0.01% | 3172 |
|
|
2015
Q4 | $15K | Sell |
453
-34,569
| -99% | -$1.14M | ﹤0.01% | 2749 |
|
|
2015
Q3 | $1.02M | Buy |
35,022
+34,642
| +9,116% | +$1M | ﹤0.01% | 1394 |
|
|
2015
Q2 | $12K | Sell |
380
-4,007
| -91% | -$127K | ﹤0.01% | 3234 |
|
|
2015
Q1 | $88K | Buy |
4,387
+3,896
| +793% | +$78.2K | ﹤0.01% | 2551 |
|
|
2014
Q4 | $8K | Buy |
491
+380
| +342% | +$6.19K | ﹤0.01% | 3829 |
|
|
2014
Q3 | $2K | Sell |
111
-1,868
| -94% | -$33.7K | ﹤0.01% | 4149 |
|
|
2014
Q2 | $67K | Buy |
1,979
+1,791
| +953% | +$60.6K | ﹤0.01% | 2923 |
|
|
2014
Q1 | $6K | Buy |
+188
| New | +$6K | ﹤0.01% | 3952 |
|